NEWS
Estimated growth slowdown in the largest therapy areas and new consuming trends
We at Norameda aim to keep a finger on the pharmaceutical market pulse and share the knowledge with our partners. So here are the latest statistics and trends. Oncology sales on increase According to the latest statistics, the main trends remain: oncology ($184 bn)...
OTC Division: meet the long-standing leader Rasa Tarvydienė
"The strength of our products – they are effective, backed by clinical trials and recommended by healthcare professionals," says Rasa Tarvydienė, The Head of the OTC Division. Like mother rising a child R. Tarvydienė is one of the long-standing leaders at Norameda....
Are the war in Ukraine and growing inflation an obstacle to pharmaceutical market recovery?
Being informed and having the latest information on the industry is vital for us at Norameda. Analysis of pharmaceutical market, impacts by pandemic, politics, economy, the war in Ukraine or digital innovations all have an effect. We want to share some insights based...
Anton Gonak, The Head of Onko & Hospital Unit, “We work for and with our clients”
Anton Gonak started to work for Norameda 14 years ago. According to the young professional, it was a “one-man show” at the time. Today A. Gonak is in charge of the whole division, working in the pharmaceutical market of Oncology, Haematology, and Transplantology....